Sort
15,842 grants matching “pancreatic cancer”
Purity Independent SIngle Sample Tumor Classifier for Pancreatic Cancer
$171,400Jen Jen Yeh · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
$171,331Andrea C Enzinger · Dana-Farber Cancer Inst · K07 · FY2020 · CA
Identifying insulin resistance biomarkers and metabolomic signature as predictors of precursors to pancreatic cancer
$171,281Jianjun Zhang · Indiana University Indianapolis · R21 · FY2017 · CA
Discovery of allele-selective KRAS inhibitors
$171,252Brent R Stockwell · Columbia Univ New York Morningside · R21 · FY2015 · CA
Molecular Pathomechanism of Hereditary Pancreatitis
$171,237Boston University Medical Campus · R01 · FY2002 · DK
Optimizing the role of ERCP in evaluating indeterminate bile duct strictures
$171,143Gregory A Cote · Medical University Of South Carolina · K23 · FY2015 · DK
Mechanistic insights into lysosomal nutrient efflux in cancer
$170,921Kacper Rogala · Stanford University · R00 · FY2023 · CA
Profiling Pancreatic Cancer Metabolism and Tumor Microenvironment for Therapy
$170,891Anne Le · Johns Hopkins University · R21 · FY2014 · CA
NMDA receptors in the diagnosis and treatment of pancreatic cancer
$170,891William G North · Dartmouth College · R21 · FY2014 · CA
Plasmalemma vesicle-associated protein (PV-1) as a novel target in cancer immunot
$170,891Radu Virgil Stan · Dartmouth College · R21 · FY2014 · CA
Targeting RAS signaling with CDK and AKT inhibition in pancreatic cancer
$170,891Nilofer S. Azad · Johns Hopkins University · R21 · FY2014 · CA
Anti-PV1 Therapy for Pancreatic Cancer
$170,890Radu Virgil Stan · Dartmouth College · R21 · FY2014 · CA
UNMC Eppley Cancer Center Support Grant
$170,863Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2006 · CA
Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors
$170,738Mansoor M. Amiji · Northeastern University · R21 · FY2017 · CA
Targeted proteomics to aid in the management of patients with stage IA lung adeno
$170,738Jeffrey A. Borgia · Rush University Medical Center · R21 · FY2018 · CA
Small molecular weight eNOS inhibitors for the treatment of pancreatic cancer
$170,738Christopher M Counter · Duke University · R21 · FY2011 · CA
Tissue Factor splicing and pancreatic tumor progression: pilot studies
$170,738Vladimir Bogdanov · University Of Cincinnati · R21 · FY2012 · CA
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
$170,683Andrew M Lowy · University Of California, San Diego · U54 · FY2024 · CA
Immunogene Ther. of Mesothelin Express. Tumors Using Lentiviral Engineered TCells
$170,642Carl H. June · University Of Pennsylvania · P01 · FY2007 · CA
Stromal Periostin in Pancreatitis and Pancreas Cancer
$170,640Rosa F. Hwang · University Of Tx Md Anderson Can Ctr · K08 · FY2009 · CA
Defining diverse roles of p53 in pancreatic cancer
$170,640Michael Paul Kim · University Of Tx Md Anderson Can Ctr · K08 · FY2021 · CA
Defining diverse roles of p53 in pancreatic cancer
$170,640Michael Paul Kim · University Of Tx Md Anderson Can Ctr · K08 · FY2017 · CA
Defining diverse roles of p53 in pancreatic cancer
$170,640Michael Paul Kim · University Of Tx Md Anderson Can Ctr · K08 · FY2020 · CA
Stromal Periostin in Pancreatitis and Pancreas Cancer
$170,640Rosa F. Hwang · University Of Tx Md Anderson Can Ctr · K08 · FY2010 · CA
Stromal Periostin in Pancreatitis and Pancreas Cancer
$170,640Rosa F. Hwang · University Of Tx Md Anderson Can Ctr · K08 · FY2012 · CA